106 related articles for article (PubMed ID: 4290978)
1. [Antigenic and immunological relationships between the A sub-types of the foot-and-mouth disease virus. 1. After inoculation of guinea-pigs with active virus].
Wittmann G
Zentralbl Veterinarmed B; 1966 Jun; 13(3):225-38. PubMed ID: 4290978
[No Abstract] [Full Text] [Related]
2. [The antigenic and immunologic properties and relations of A subtypes of the foot-and-mouth disease virus. II. After vaccination of guinea pigs with formalin-adsorbate].
Wittmann G
Zentralbl Veterinarmed B; 1966 Aug; 13(4):321-33. PubMed ID: 4292121
[No Abstract] [Full Text] [Related]
3. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
Warrington RE; Cunliffe HR; Bachrach HL
Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
[No Abstract] [Full Text] [Related]
4. Three variants of foot-and-mouth disease virus type O: cell culture characteristics and antigenic differences.
McVicar JW; Sutmoller P
Am J Vet Res; 1972 Aug; 33(8):1627-33. PubMed ID: 4340052
[No Abstract] [Full Text] [Related]
5. Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines.
Terpstra C; Frenkel S; Straver PJ; Barteling SJ; van Bekkum JG
Dev Biol Stand; 1976; 35():333-42. PubMed ID: 198304
[No Abstract] [Full Text] [Related]
6. Neutralizing activity of sera from guinea-pigs inoculated with foot-and-mouth disease virus variants.
Martinsen JS
Res Vet Sci; 1972 Jan; 13(1):97-9. PubMed ID: 4336056
[No Abstract] [Full Text] [Related]
7. [Subtypes of the foot-and-mouth disease virus type O. Their antigenic and immunologic properties and mutual relationships].
Wittmann G
Zentralbl Bakteriol Orig; 1964 Sep; 194(1):1-25. PubMed ID: 4284199
[No Abstract] [Full Text] [Related]
8. [Preliminary study of the combination of anti-foot-and-mouth disease and anti-brucellosis vaccines].
Mastan MB; Amighi M; Ardelan A; Bandpay MR; Ebadi A; Farsi J
Dev Biol Stand; 1976; 35():437-43. PubMed ID: 198311
[TBL] [Abstract][Full Text] [Related]
9. [Biological properties of virus strains, reproduced from infectious ribonucleic acid neurotropic foot-and-mouth disease virus mutants].
Veckenstedt A; Hantschel H
Arch Exp Veterinarmed; 1966 Jun; 20(3):581-7. PubMed ID: 4296901
[No Abstract] [Full Text] [Related]
10. [Comparative trial of the immunogenic properties of commercial foot-and-mouth virus strains].
Tekerlekov P; Nikolova E
Vet Med Nauki; 1981; 18(1):19-26. PubMed ID: 6272473
[TBL] [Abstract][Full Text] [Related]
11. [Antigenic properties of some strains of foot-and-mouth disease virus].
Bazadze TsV
Veterinariia; 1971 Aug; 9():34-5. PubMed ID: 4334672
[No Abstract] [Full Text] [Related]
12. [Foot-and-mouth virus component responsible for immunogenesis].
Salazhov EL; Ivanov VS
Veterinariia; 1970 Sep; 9():38-40. PubMed ID: 4323895
[No Abstract] [Full Text] [Related]
13. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
Dunn CS; Samuel AR; Pullen LA; Anderson J
Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cross reacting isolates of foot & mouth disease virus.
Venkataramanan R; Mukhopadhyay AK; Rao BU
Indian J Exp Biol; 1983 Mar; 21(3):137-42. PubMed ID: 6197366
[No Abstract] [Full Text] [Related]
15. [Early immunity stages following inoculation of pigs with a foot-and-mouth-disease DEAE dextran vaccine].
Wittmann G
Zentralbl Veterinarmed B; 1972 May; 19(5):406-11. PubMed ID: 4340583
[No Abstract] [Full Text] [Related]
16. [Antigenic properties of foot-and-mouth disease virus strain Ai].
Darda PN; Salazhov EL; Antoniuk VP; Likhachev NV
Veterinariia; 1966 Jan; 43(1):20-2. PubMed ID: 4293892
[No Abstract] [Full Text] [Related]
17. [Antigenic properties of type C foot-and-mouth disease virus].
Fomina MS; Driagalin NN; Shazhko ZhA; Onofriev VP
Veterinariia; 1970 Sep; 9():40-2. PubMed ID: 4323896
[No Abstract] [Full Text] [Related]
18. Protection of guinea-pigs against foot-and-mouth disease by simultaneous inoculation of sendai virus and inactivated foot-and-mouth disease vaccine.
Herniman KA; Sellers RF
Arch Gesamte Virusforsch; 1972; 37(1):97-103. PubMed ID: 4336969
[No Abstract] [Full Text] [Related]
19. [Role of antibodies in the antigenic variability of the foot-and-mouth disease virus].
Salazhov EL; Avilov VS; Rebenkov AG
Veterinariia; 1976; (9):31-2. PubMed ID: 186935
[No Abstract] [Full Text] [Related]
20. Serological behaviour of cross reacting foot & mouth disease virus isolates.
Venkataramanan R; Mukhopadhyay AK; Rao BU
Indian J Exp Biol; 1983 Mar; 21(3):134-6. PubMed ID: 6197365
[No Abstract] [Full Text] [Related]
[Next] [New Search]
